Norinchukin Bank’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.93M | Buy |
33,601
+1,953
| +6% | +$170K | 0.04% | 232 |
|
|
2025
Q1 | $2.16M | Buy |
31,648
+9,608
| +44% | +$656K | 0.04% | 257 |
|
|
2024
Q4 | $1.71M | Buy |
22,040
+1,664
| +8% | +$129K | 0.04% | 261 |
|
|
2024
Q3 | $1.37M | Buy |
20,376
+3,033
| +17% | +$203K | 0.03% | 296 |
|
|
2024
Q2 | $1.97M | Buy |
17,343
+860
| +5% | +$97.5K | 0.06% | 186 |
|
|
2024
Q1 | $2.29M | Sell |
16,483
-372
| -2% | -$51.6K | 0.07% | 174 |
|
|
2023
Q4 | $2.09M | Sell |
16,855
-2,253
| -12% | -$280K | 0.05% | 175 |
|
|
2023
Q3 | $1.78M | Sell |
19,108
-17,198
| -47% | -$1.6M | 0.04% | 205 |
|
|
2023
Q2 | $4.67M | Buy |
36,306
+7,048
| +24% | +$906K | 0.08% | 164 |
|
|
2023
Q1 | $3.4M | Buy |
29,258
+759
| +3% | +$88.2K | 0.07% | 167 |
|
|
2022
Q4 | $3.23M | Sell |
28,499
-6,019
| -17% | -$682K | 0.07% | 165 |
|
|
2022
Q3 | $2.78M | Buy |
34,518
+3,022
| +10% | +$243K | 0.06% | 202 |
|
|
2022
Q2 | $2.35M | Sell |
31,496
-8,316
| -21% | -$620K | 0.05% | 224 |
|
|
2022
Q1 | $5.09M | Buy |
39,812
+3,400
| +9% | +$435K | 0.07% | 165 |
|
|
2021
Q4 | $4.89M | Sell |
36,412
-2,188
| -6% | -$294K | 0.06% | 165 |
|
|
2021
Q3 | $5.28M | Buy |
38,600
+2,168
| +6% | +$296K | 0.07% | 144 |
|
|
2021
Q2 | $3.89M | Buy |
36,432
+700
| +2% | +$74.7K | 0.06% | 171 |
|
|
2021
Q1 | $3.21M | Buy |
35,732
+1,688
| +5% | +$152K | 0.04% | 192 |
|
|
2020
Q4 | $3.15M | Sell |
34,044
-36
| -0.1% | -$3.33K | 0.04% | 173 |
|
|
2020
Q3 | $3.51M | Buy |
34,080
+2,192
| +7% | +$226K | 0.06% | 147 |
|
|
2020
Q2 | $3.23M | Buy |
+31,888
| New | +$3.23M | 0.06% | 153 |
|